Search

Your search keyword '"Papenfuss, Anthony T"' showing total 808 results

Search Constraints

Start Over You searched for: Author "Papenfuss, Anthony T" Remove constraint Author: "Papenfuss, Anthony T"
808 results on '"Papenfuss, Anthony T"'

Search Results

1. The tidyomics ecosystem: enhancing omic data analyses

4. Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b

5. Targeting homologous recombination deficiency in uterine leiomyosarcoma

6. A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq

10. A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin

12. Women with type 1 diabetes exhibit a progressive increase in gut Saccharomyces cerevisiae in pregnancy associated with evidence of gut inflammation

13. Correction: Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

14. Whole genome analysis of a schistosomiasis-transmitting freshwater snail.

15. Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

16. Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression

20. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

21. Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine

28. Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

29. Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

30. A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review

32. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer

35. Taurine deficiency as a driver of aging

38. cellsig plug-in enhances CIBERSORTx signature selection for multidataset transcriptomes with sparse multilevel modelling.

40. Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer

41. Supplementary Table S1 from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

42. Data from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

43. Supplementary Figures from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

44. Figure S2 from Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma

45. Supplemental Legends from Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma

46. Supplementary Figure Legend from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

47. Supplementary Table 2 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

48. Supplementary Figure 1 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

49. Supplementary Tables 1, 3 and 4 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

50. Supplementary Figure S4 from CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity

Catalog

Books, media, physical & digital resources